Enzo Biochem (ENZ) Misses Q2 EPS by 1c

Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $24.43 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Isabella Bank added to Russell 2000 index after Nasdaq listing
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT